A case of paraneoplastic myelopathy associated with the neuromyelitis optica antibody

Nature Clinical Practice Neurology

Volumn 4, Issue 5, 2008, Pages 284-288

  Mueller, Sabine ^a   Dubal, Dena B ^a,b   Josephson, S Andrew ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLADSTONE INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AUTOANTIBODY; BEVACIZUMAB; CAPECITABINE; CORTICOSTEROID; DEXAMETHASONE; FLUORODEOXYGLUCOSE F 18; METHYLPREDNISOLONE SODIUM SUCCINATE; NEUROMYELITIS OPTICA ANTIBODY; PACLITAXEL; PREDNISONE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER RECURRENCE; CASE REPORT; CELIAC DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; ELECTROENCEPHALOGRAPHY; EVENING DOSAGE; EVOKED AUDITORY RESPONSE; EVOKED BRAIN STEM RESPONSE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; LABORATORY TEST; LIMB WEAKNESS; LUMBAR PUNCTURE; LYMPH NODE BIOPSY; MORNING DOSAGE; MULTIPLE CYCLE TREATMENT; NEUROOPHTHALMOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC SPINAL CORD DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEROLOGY; SPINAL CORD DISEASE; SYMPTOM; THORAX PAIN; TREATMENT DURATION; URINE RETENTION;

AUTOANTIBODIES; BREAST NEOPLASMS; CERVICAL VERTEBRAE; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; NEUROMYELITIS OPTICA; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; SPINAL CORD DISEASES; THORACIC VERTEBRAE;

EID: 43149098261     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0765     Document Type: Article

References (13)

1. Altaha R and Abraham J (2003) Paraneoplastic neurologic syndrome associated with occult breast cancer: A case report and review of literature. Breast J 9: 417-419
2. Ojeda VJ (1984) Necrotizing myelopathy associated with malignancy: A clinicopathologic study of two cases and literature review. Cancer 53: 1115-1123
3. Lennon VA et al. (2004) A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 364: 2106-2112
4. Lennon VA et al. (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202 473-477
5. Amiry-Moghaddam M and Ottersen OP (2003) The molecular basis of water transport in the brain. Nat Rev Neurosci 4: 991-1001
6. Pittock SJ et al. (2006) Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63: 964-968
7. Wingerchuk DM (2007) Diagnosis and treatment of neuromyelitis optica. Neurologist 13: 2-11
8. Jacob S et al. (2006) Gluten sensitivity and neuromyelitis optica: two case reports. J Neurol Neurosurg Psychiatry 76: 1028-1030
9. Thielen KR and Miller GM (1996) Multiple sclerosis of the spinal cord: magnetic resonance appearance. J Comput Assist Tomogr 20: 434-438
10. Wingerchuk DM and Weinshenker BG (2005) Neuromyelitis optica. Curr Treat Options Neurol 7: 173-182
11. Wingerchuk DM et al. (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53: 1107-1114
12. Jacob A et al. (2007) Neuromyelitis optica: Changing concepts. J Neuroimmunol 187: 126-138
13. Cree BA et al. (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64: 1270-1272